These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 9021828)
1. Maternal serum alpha-fetoprotein and epithelial tumour marker concentrations are not increased by fetal sacrococcygeal teratoma. Kirkinen P; Heinonen S; Vanamo K; Ryynänen M Prenat Diagn; 1997 Jan; 17(1):47-50. PubMed ID: 9021828 [TBL] [Abstract][Full Text] [Related]
2. Prenatal screening for fetal aneuploidy in singleton pregnancies. Chitayat D; Langlois S; Douglas Wilson R; ; J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752 [TBL] [Abstract][Full Text] [Related]
3. Prenatal screening for trisomy 18 with free beta human chorionic gonadotrophin as a marker. Spencer K; Mallard AS; Coombes EJ; Macri JN BMJ; 1993 Dec; 307(6917):1455-8. PubMed ID: 7506599 [TBL] [Abstract][Full Text] [Related]
4. Comparison of second-trimester maternal serum free-beta-human chorionic gonadotropin and alpha-fetoprotein between normal singleton and twin pregnancies: a population-based study. Zheng MM; Hu YL; Zhang CY; Ru T; Liu QL; Xu BY; Chen QG; Xu ZF; Zhang Y; Zhong XL Chin Med J (Engl); 2010 Mar; 123(5):555-8. PubMed ID: 20367980 [TBL] [Abstract][Full Text] [Related]
5. Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review. Spencer K Br J Obstet Gynaecol; 1999 Dec; 106(12):1287-93. PubMed ID: 10609723 [TBL] [Abstract][Full Text] [Related]
7. [Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study]. Qi QW; Jiang YL; Liu JT; Bian XM; Li Y; Lü SM; Zhu BS; Wang H; Xu ZF; Pan XY; Cai Y Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):737-41. PubMed ID: 19087538 [TBL] [Abstract][Full Text] [Related]
8. First trimester biochemical screening for trisomy 21: the role of free beta hCG, alpha fetoprotein and pregnancy associated plasma protein A. Spencer K; Aitken DA; Crossley JA; McCaw G; Berry E; Anderson R; Connor JM; Macri JN Ann Clin Biochem; 1994 Sep; 31 ( Pt 5)():447-54. PubMed ID: 7530437 [TBL] [Abstract][Full Text] [Related]
9. Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. Yaron Y; Cherry M; Kramer RL; O'Brien JE; Hallak M; Johnson MP; Evans MI Am J Obstet Gynecol; 1999 Oct; 181(4):968-74. PubMed ID: 10521763 [TBL] [Abstract][Full Text] [Related]
10. Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study. Kellner LH; Weiner Z; Weiss RR; Neuer M; Martin GM; Mueenuddin M; Bombard A Am J Obstet Gynecol; 1995 Oct; 173(4):1306-9. PubMed ID: 7485343 [TBL] [Abstract][Full Text] [Related]
11. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome]. Liao S; Wang Y; Ye G Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764 [TBL] [Abstract][Full Text] [Related]
12. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy. Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718 [TBL] [Abstract][Full Text] [Related]
13. Elevated second-trimester maternal serum β-human chorionic gonadotropin and amniotic fluid alpha-fetoprotein as indicators of adverse obstetric outcomes in fetal Turner syndrome. Alvarez-Nava F; Soto M; Lanes R; Pons H; Morales-Machin A; Bracho A J Obstet Gynaecol Res; 2015 Dec; 41(12):1891-8. PubMed ID: 26369382 [TBL] [Abstract][Full Text] [Related]
14. Maternal serum alpha-fetoprotein and human chorionic gonadotrophin in a pregnancy complicated by fetal sacrococcygeal teratoma. Lam YH; Lee CP; Tang MH Prenat Diagn; 1997 Nov; 17(11):1085. PubMed ID: 9399360 [No Abstract] [Full Text] [Related]
15. Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening. Berry E; Aitken DA; Crossley JA; Macri JN; Connor JM Prenat Diagn; 1995 Jun; 15(6):555-65. PubMed ID: 7544898 [TBL] [Abstract][Full Text] [Related]
19. [Second trimester maternal serum screening for Down's syndrome in mainland China: a multi-center prospective study]. Bian XM; Liu JT; Qi QW; Jiang YL; Li Y; Liu SY; Hao N; Zhou J; Lü SM; Zhu BS; Wang H; Xu ZF; Pan XY; Liao C; Cai Y; Wang H; Wang Z; Zhu J; Hu YL Zhonghua Fu Chan Ke Za Zhi; 2008 Nov; 43(11):805-9. PubMed ID: 19087560 [TBL] [Abstract][Full Text] [Related]
20. Uptake of prenatal screening for chromosomal anomalies: impact of test results in a previous pregnancy. Spencer K Prenat Diagn; 2002 Dec; 22(13):1229-32. PubMed ID: 12478639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]